Bryan T Baldasare's Net Worth
$424 Thousand
Who is Bryan T Baldasare?
Bryan T Baldasare does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MERIDIAN BIOSCIENCE INC, and InMed Pharmaceuticals Inc..
SEC CIK
Bryan T Baldasare's CIK is 0001761920
Past Insider Trading and Trends
2020 was Bryan T Baldasare's most active year for acquiring shares with 5 total transactions. Bryan T Baldasare's most active month to acquire stocks was the month of October. 2021 was Bryan T Baldasare's most active year for disposing of shares, totalling 7 transactions. Bryan T Baldasare's most active month to dispose stocks was the month of January. 2021 saw Bryan T Baldasare paying a total of $293,400.00 for 69,819 shares, this is the most they've acquired in one year. In 2021 Bryan T Baldasare cashed out on 73,853 shares for a total of $679,065.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MERIDIAN BIOSCIENCE INC No price found
Exec VP & CFOBryan T Baldasare owns 60,929 units of Common Stock.acquired a total of 94,207 shares in MERIDIAN BIOSCIENCE INC at a cost of $336,901.00, Bryan also disposed a total of 64,149 shares of MERIDIAN BIOSCIENCE INC equalling to $761,109.69.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.16% | -1.99K |
$17.92 | -$35,571.20 | 60.93K |
Dec 15
| |||
Form 4
| -5.71% | -3.81K |
$20.16 | -$76,749.12 | 62.91K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
| 66.72K |
Nov 15
| |||
Form 4
| +18.87% | 10.59K |
—
|
—
| 66.72K |
Nov 4
| |||
Form 4
| -4.27% | -2.50K |
$24.78 | -$114,270.00 | 56.13K |
Scheduled
|
Feb 8
| ||
Form 4
| -4.87% | -3.00K |
$23.09 | -$159,075.52 | 58.63K |
Scheduled
|
Feb 5
| ||
Form 4
| -3.13% | -1.99K |
$17.11 | -$34,059.04 | 61.63K |
Nov 16
| |||
Form 4
| +20.50% | 10.82K |
—
|
—
| 63.62K |
Nov 5
| |||
Form 4
| +0.31% | 163 |
$21.50 | -$1,573.73 | 52.8K |
Jun 30
| |||
Form 4
| +3.95% | 2K |
$6.97 | $13,936.00 | 52.64K |
Mar 10
| |||
Form 4
| -3.74% | -1.97K |
$8.56 | -$16,846.08 | 50.64K |
Nov 18
| |||
Form 4
| +64.03% | 20.53K |
—
|
—
| 52.6K |
Oct 31
| |||
Form 4
| +3.89% | 1.2K |
—
|
—
| 32.07K |
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
InMed Pharmaceuticals Inc. (INM) Snapshot price: $0.2718
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||